Ophthalmological examination
Sponsors
Cairo University, University Hospital, Toulouse, Poitiers University Hospital, Centre Hospitalier Universitaire Dijon, Region Örebro County
Conditions
Ibrutinib TreatmentIchthyosisMast Cell Activation DiseaseMast Cell Activation SyndromeMast Cell DiseaseMicrovascular AnginaMyopiaPrimary Antiphospholipid Syndrome
Unknown Phase
Ocular Findings in Women With Primary Antiphospholipid Syndrome
CompletedNCT03459508
Start: 2017-12-01End: 2018-10-23Updated: 2018-10-24
Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)
CompletedNCT03464994
Start: 2017-07-18End: 2022-06-30Updated: 2025-12-31
Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)
CompletedNCT04978740
Start: 2021-07-30End: 2021-09-03Updated: 2022-12-01
Cardiovascular Complications of Ibrutinib Therapy
TerminatedNCT05939752
Start: 2023-12-20End: 2025-08-05Updated: 2026-02-27
The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).
RecruitingNCT06692751
Start: 2024-11-13End: 2027-11-01Target: 158Updated: 2026-02-17
Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study
RecruitingNCT07174141
Start: 2025-11-28End: 2028-11-30Target: 100Updated: 2025-12-04
Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth
RecruitingNCT07653074
Start: 2024-10-27End: 2029-05-30Target: 300Updated: 2026-09-01